Episode 73: Genentech's Quita Highsmith - a podcast by The MM+M Podcast

Genentech isn’t currently developing a SARS-CoV-2 vaccine or therapeutic, but the biotech has been conducting research that could bring insight to bear on the willingness among communities of color to engage in clinical trials for COVID-19 vaccines and treatments. Quita Highsmith, Genentech’s chief diversity officer, speaks about that, and the biotech’s own efforts to recruit and instill more trust among underserved and medically disenfranchised patients.

Further episodes of The MM+M Podcast

Further podcasts by The MM+M Podcast

Website of The MM+M Podcast